通过使用特权结构二二来设计的衍生物的毒性评估:LQFM310,一个尼菲迪平类型的类似物
Amanda C Silva1,2, Michele R Machado2, Gerlon A R Oliveira3
1Laboratory of Medicinal Pharmaceutical Chemistry (LQFM), School of Pharmacy, Federal University of Goiás, Goiânia, Goiás, Brazil.
一种新型化合物,LQFM310,是通过分子杂交合成的,它结合了二二和丁氧 (BHT) 特性. 与nifedipine相比,LQFM310在斑马鱼胚胎中表现出抗氧化能力和更安全的毒理学特征.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 像二皮里丁这样的特权结构是生物活性化合物的关键,通常与心血管疾病的通道阻塞 (例如,尼菲迪平) 有关.
- 虽然通常是安全的,但一些二皮里丁化合物可能会产生不良影响;已知尼菲迪平具有致病性和胚胎毒性.
- 分子杂交是一种通过结合有益的结构动机来创造新药候选物的策略.
研究的目的:
- 设计和合成一种新型化合物,LQFM310,通过将尼菲迪平基架与丁酸 (BHT) 混合化.
- 通过电化学分析和斑马鱼 (Danio rerio) 胚胎-幼虫试验,评估LQFM310的抗氧化能力和毒理学概况.
- 在斑马鱼毒性模型中,比较LQFM310与尼菲迪平的安全性.
主要方法:
- 合成LQFM310的分子杂交策略,其中包括二甲基2,6-二甲基-1,4-二胺-3,5-二碳酸盐和丁酸 (BHT).
- 电化学分析以评估抗氧化剂活性.
- 斑马鱼 (Danio rerio) 胚胎-幼虫毒性测定,以评估致命和次致命影响,比较LQFM310与尼菲迪平.
主要成果:
- LQFM310显示出显著的抗氧化能力.
- 在斑马鱼胚胎和幼虫中,LQFM310没有诱导显著的致命或次致命效应.
- 在斑马鱼中,nifedipine在25μM时诱导了100%的死亡率,在10μM时诱导了亚致命效应,这表明毒性明显更高.
结论:
- 在斑马鱼模型中,LQFM310表现出比nifedipine更安全的毒理特征.
- 尼菲迪平中的酸芳香基架可能导致其毒性.
- 含有特权二皮里丁结构的LQFM310是进一步药理学研究的有希望的候选者.
更多相关视频
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
08:46Author Spotlight: Innovative Methods in Lymphedema and Hypertension Research
Published on: March 22, 2024
相关概念视频
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Inotropic Agents
Antihypertensive Drugs: Action of Calcium Channel Blockers
